Dennis E. Mayock, MD

Dennis E. Mayock, MD


On staff since March 1985

Children's Title: Associate Division Chief, Clinical Research

Academic Title: Professor of Pediatrics

Research Center: Center for Clinical and Translational Research

"My goal is to provide the best evidenced-based medical care to newborns. When evidence is not available on which to base clincal decisions, I feel obligated to pursue such answers through clinical research projects. Generation of new evidence remains my primary focus."

Dr. Mayock's basic research interests include evaluation of the effects of fetal and neonatal drug (alcohol, morphine) exposure on fetal, neonatal and adult cerebrovascular function. Dr. Mayock's clinical research interests include evaluation of therapies that potentially may improve the outcomes in infants at risk for neurodevelopmental impairment, and treatments that may alter the likehood of developing Bronchopulmonary Dysplasia such as inhaled nitric oxide and late surfactant treatments.

In collaboration with Drs. Juul and Gleason, he is evaluating whether high dose erythropoietin treatment has neuroprotective effects in preterm and term infants. In collaboration with Dr. Meghan Delaney, he is exploring different methods of protecting infants from transfusion related CMV disease.


Board Certification(s)

Neonatal-Perinatal Medicine

Medical/Professional School

Ohio State University College of Medicine, Columbus


Neonatal-Perinatal Medicine, University of Washington, Seattle

Clinical Interests

Cerebrovascular function in neonates, RSV, Nitric oxide clinical trials

Awards and Honors

Award Name Award Description Awarded By Award Date
Seattle's Top Doctor Seattle Magazine 2014
Seattle's Top Doctor Seattle Magazine 2012
David E. Woodrum Faculty Teaching Award UW Divsion of Neonatology 2012
U.S. News Top Doctor U.S. News and World Report 2012


  • Shankaran S, Lin A, Maller-Kesselman J, Zhang H, O'Shea TM, Bada HS, Kaiser JR, Lifton RP, Bauer CR, Ment LR, Gene Targets for Intraventricular Hemorrhage Study
    Maternal race, demography, and health care disparities impact risk for intraventricular hemorrhage in preterm neonates.
    The Journal of pediatrics , 2014 May : 164(5)1005-1011.e3
  • Dennis E. Mayock, MD
    Neonatal morbidity occurs despite pulmonary maturity prior to 39 weeks gestation
    Journal of Perinatology , 2014 Apr, : 34(4)322-325
  • Dennis E. Mayock, MD
    Geneenvironment interactions in severe intraventricular hemorrhage of preterm neonates
    Pediatric Research , 2014 : 75(1)241-250
  • Adén U, Lin A, Carlo W, Leviton A, Murray JC, Hallman M, Lifton RP, Zhang H, Ment LR, Gene Targets for Intraventricular Hemorrhage Study Group
    Candidate gene analysis: severe intraventricular hemorrhage in inborn preterm neonates.
    The Journal of pediatrics , 2013 Nov. : 163(5)1503-6.e1
  • Dennis E. Mayock, MD
    Canadidate Gene Analysis:severe intraventricular hemorrhage in inborn preterm neonates
    J Periatr , 2013 June 25
  • Chabra S, Mayock DE, Zerzan J, Bittner R, Neufeld MD, Gleason CA
    Vitamin A Status After Prophylactic Intramuscular Vitamin A Supplementation in Extremely Low Birth Weight Infants.
    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition , 2013 Mar. 5
  • Dennis E. Mayock, MD
    Pain and Sedation in the Neonatal ICU.
    NeoReviews , 2013 : 14e22-e31
  • Dennis E. Mayock, MD
    Outcomes of extremely low birth weight infants given early high-dose erythropoietin
    J Perinatol , 2013 : 33226-230

Research Funding

Grant Title Grantor Amount Award Date
Neonatal CMV infection: a comparative effectiveness study of transfusion safety Department of Pediatrics AEF 2013 - 2015
Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) NINDS 1U01NS077953-01 $10,255,370 2013 - 2018
Neonatal Erythropoietin and Therapeutic Hypothermia Short-Term Outcome Study (NEAT O Study). Trasher Foundation $7,869 2013 - 2016
Darbe Administration in Newborns Undergoing Cooling for Encephalopathy (DANCE Trial) Trasher Grant $41,994 2012 - 2014
Gene Targets for IVH NINDS 2010 - 2012
Phase I Multicenter Clinical Trial of Early High-Dose Erythropoietin in Term Infants with Hypoxic-Ischemic Encephalopathy (NEAT Trial) Thrasher Foundation 2010 - 2013
U01 (Subcontract to Ballard); NHLBI; Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia (BPD): The TOLSURF Study $155,042 Sept. 15, 2009 - July 31, 2014